Galantamine improves cognition, behavioral symptoms and functioning: a 6-month non-interventional study

Galantamine improves cognition, behavioral symptoms and functioning: a 6-month non-interventional study

Bibliographic Details
Main Authors:	Fortos Andreas, Gatos Konstantinos, Varelas Georgios, Vagenas Vassileios, Sakka Paraskevi, Rigopoulou Stamatia, Papatriantafyllou Ioannis, Makris Nikolaos, Kontogianni Vassiliki, Fitsioris Xenofon, Politis Antonios, Tsolaki Magdalini, Oikonomidis Dimitrios, Giatas Konstantinos, Doskas Triantafyllos, Taskos Nikolaos, Mestoussi Angeliki, Vikelis Michalis
Format:	Article
Language:	English
Published:	BMC 2010-04-01
Series:	Annals of General Psychiatry

Similar Items

Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
by: Yukio Ago, et al.
Published: (2011-01-01)

Cytokine gene polymorphism in multiple sclerosis in a hellenic population
by: Voumvourakis Konstantinos, et al.
Published: (2008-04-01)

Galantamine's Deconstruction in the Quest of a PAM Pharmacophore
by: Argade, Malaika
Published: (2018)

QT interval prolongation and with donepezil, rivastigmine and galantamine
by: Katie Malone, et al.
Published: (2020-08-01)

A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer’s disease treated with rivastigmine transdermal patch
by: Vassileios Vagenas, et al.
Published: (2015-06-01)

A simple and direct HPLC-DAD method for the simultaneous determination of galantamine, donepezil and rivastigmine in cerebrospinal fluid, blood serum and urine
by: Maria Petrocheilou, et al.
Published: (2017-06-01)

Galantamine plasma concentration and cognitive response in Alzheimer’s disease
by: Yi-Ting Lin, et al.
Published: (2019-05-01)

Determination of galantamine in rat blood by microdialysis and liquid chromatography
by: Yi-Chieh Mai, et al.
Published: (2010)

A Systematic Review of Peripheral and Central Nervous System Involvement of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Primary Sjögren’s Syndrome, and Associated Immunological Profiles
by: Anastasia Bougea, et al.
Published: (2015-01-01)

Corrigendum to “A Systematic Review of Peripheral and Central Nervous System Involvement of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Primary Sjögren’s Syndrome, and Associated Immunological Profiles”
by: Anastasia Bougea, et al.
Published: (2016-01-01)

Hierarchical Porous Carbon—PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer’s Disease Therapy
by: Stavroula G. Nanaki, et al.
Published: (2020-03-01)

Ameliorative effect of galantamine on acetic acid-induced colitis in rats
by: Niloofar-Sadat Mahdavi, et al.
Published: (2019-01-01)

CAN WE PREDICT THE RESPONSE TO GALANTAMINE IN ALZHEIMER`S DISEASE PATIENTS?
by: Carmen Gavan, et al.
Published: (2015-09-01)

Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors
by: Georgi Stavrakov, et al.
Published: (2020-07-01)

Changes in electrophysiological markers of cognitive control after administration of galantamine
by: Lauren E. Gascoyne, et al.
Published: (2018-01-01)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
by: Ben Seltzer
Published: (2009-12-01)

Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine
by: Maju Mathew Koola
Published: (2016-06-01)

Galantamine-memantine combination effective in dementia: Translate to dementia praecox?
by: Maju Mathew Koola, et al.
Published: (2018-06-01)

Preparation and evaluation of novel galantamine hydrobromide sustained-release capsule
by: Shuoye Yang
Published: (2016-03-01)

Real-time extensions of April for time-aware multi-agent systems programming
by: Prouskas, Konstantinos-Vassileios
Published: (2002)

Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study)
by: Paulo Caramelli, et al.
Published: (2014-06-01)

Determination of galantamine hydrobromide in bulk drug and pharmaceutical dosage form by spectrofluorimetry
by: Amit V Patel, et al.
Published: (2013-01-01)

Synergistic Effects of Galantamine and Memantine in Attenuating Scopolamine-Induced Amnesia in Mice
by: Perrine Busquet, et al.
Published: (2012-01-01)

Long-term efficacy and safety of galantamine in outpatients with mild cognitive disorder
by: Schmidt Luisa, et al.
Published: (2010-04-01)

Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina
by: Cristiane Bezerra da Silva, et al.
Published: (2016-01-01)

Galantamine protects against lipopolysaccharide-induced acute lung injury in rats
by: G. Li, et al.
Published: (2016-01-01)

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
by: E Loveman, et al.
Published: (2006-01-01)

Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma
by: Sarah Naguib, et al.
Published: (2020-02-01)

The Effect of Galantamine on Liver Function in Hepatic Ischemia/Reperfusion Injury in Rats
by: Majid Askaripour, et al.
Published: (2019-06-01)

Solitary Cecal Diverticulitis: An Unusual Cause of Acute Right Iliac Fossa Pain—A Case Report and Review of the Literature
by: Nikolaos Mudatsakis, et al.
Published: (2014-01-01)

Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug.
by: Mennatallah A Ali, et al.
Published: (2015-01-01)

Hydroxypropyl Methylcellulose-Based Hydrogel Copolymeric for Controlled Delivery of Galantamine Hydrobromide in Dementia
by: Sidra Bashir, et al.
Published: (2020-10-01)

Formulation and Evaluation of Galantamine Gel as Drug Reservoir in Transdermal Patch Delivery System
by: Woo Fong Yen, et al.
Published: (2015-01-01)

Effects of Galantamine and Donepezil on Active and Passive Avoidance Tests in Rats With Induced Hypoxia
by: Dimitrova Darinka Slavcheva, et al.
Published: (2006-01-01)

Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteers
by: Darunee Hongwiset, et al.
Published: (2020-01-01)

Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI
by: Jolien F. Leijenaar, et al.
Published: (2020-01-01)

Galantamine Effects on Memory, Spatial Cue Utilization, and Neurotrophic Factors in Aged Female Rats
by: K. L. French, et al.
Published: (2007-03-01)

Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice
by: Yi Liu, et al.
Published: (2018-04-01)

Comparative X-Ray study of galantamine and tacrine on the evacuatory function of rat gastrointestinal tract
by: Kristev Athanas, et al.
Published: (2008-03-01)

Active and passive aeroelastic control of long-span suspension bridges
by: Bakis, Konstantinos Nikolaos
Published: (2016)